A substantial insider activity was disclosed on February 21, as Winters, VP at West Pharmaceutical Servs WST, reported the exercise of a large sell of company stock options. What Happened: A Form 4 ...

We recently published a list of These Were Last Week’s 10 Worst Performers. In this article, we are going to take a look at ...

Currently, West Pharmaceutical Servs shares are trading up 2.21%, priced at $208.15 during Friday's morning. This values MacKay's 0 shares at $0.

West Pharmaceutical Services Inc. closed 47.37% below its 52-week high of $400.88, which the company reached on March 21st.

West Pharmaceutical Services (WST) stock plummeted 38% on Thursday, making it the biggest decliner in the S&P 500. The sharp ...

West Pharmaceutical Services forecast full-year profit and revenue below Wall Street estimates on Thursday due to a strong ...

West Pharmaceutical Services Inc.’s stock tumbled 33% Thursday, to lead S&P 500 decliners, after the manufacturer of ...

West Pharmaceutical’s earnings results led to a 38% drop. Find out why WST stock could be worth watching for future rebounds ...

CIBC Asset Management Inc raised its position in shares of West Pharmaceutical Services, Inc. (NYSE:WST – Free Report) by 4.5% in the fourth quarter, HoldingsChannel reports. The firm owned 11,058 ...

Shares of healthcare products company West Pharmaceutical Services (NYSE:WST) fell 34.9% in the afternoon session after the ...

Healthcare products company West Pharmaceutical Services (NYSE:WST) reported Q4 CY2024 results topping the market’s revenue ...